(1R,3S)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran: a potent and selective D1 agonist.
DeNinno
M P
MP
Neuroscience Research, Pharmaceutical Discovery, Abbott Laboratories, Abbott Park, Illinois 60064.
Schoenleber
R
R
Asin
K E
KE
MacKenzie
R
R
Kebabian
J W
JW
D000818:Animals; D001552:Benzazepines / Q000031:analogs & derivatives / Q000378:metabolism; D001667:Binding, Competitive; D002839:Chromans / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D015259:Dopamine Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D015394:Molecular Structure; D016627:Oxidopamine; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology*; D017447:Receptors, Dopamine D1; D013237:Stereoisomerism
C049558:8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol; D001552:Benzazepines; D002839:Chromans; D015259:Dopamine Agents; D006892:Hydroxydopamines; D011954:Receptors, Dopamine; D017447:Receptors, Dopamine D1; D016627:Oxidopamine; C065380:A 68930